Cutera, Inc. (CUTR)
Pre-market:
| Previous close | 2.4500 |
| Open | 2.4500 |
| Bid | 2.5700 x 600 |
| Ask | 2.6200 x 300 |
| Day's range | 2.4000 - 2.6000 |
| 52-week range | 1.2800 - 21.4100 |
| Volume | |
| Avg. volume | 1,049,659 |
| Market cap | 51.299M |
| Beta (5Y monthly) | 1.67 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Cutera to Announce First Quarter Results on May 9, 2024
BRISBANE, Calif., April 26, 2024--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 9, 2024.
- Business Wire
Cutera® Announces the North America Launch of xeo®+
BRISBANE, Calif., April 11, 2024--Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announces the launch of xeo+, a pioneering laser and light-based multi-application platform built on a rich history of excellence in performance and innovation. The xeo+ offers providers updated features and newly redesigned handpieces that allow for faster treatment times, optimized ease of use and an improved treatment experience.
- Business Wire
Cutera Announces Fourth Quarter and Full-Year 2023 Financial Results Along with 2024 Outlook
BRISBANE, Calif., March 21, 2024--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today reported financial results for the fourth quarter and full-year ended December 31, 2023.
